コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ic conditions, such as Alzheimer disease and normal pressure hydrocephalus.
2 al biopsies taken during shunt placement for Normal Pressure Hydrocephalus.
3 erative disease and CNS injuries, as well as normal pressure hydrocephalus.
4 rol samples were obtained from patients with normal pressure hydrocephalus.
5 standing hydrocephalus as well as idiopathic normal pressure hydrocephalus.
7 hydrocephalus, neurodegeneration in elderly normal pressure hydrocephalus and, in all age groups, in
9 tasets containing 12 volumes with idiopathic normal pressure hydrocephalus (iNPH) and 30 normal volum
14 eral blood and ventricular CSF in idiopathic normal pressure hydrocephalus (iNPH) patients totaling 1
16 ical outcomes, with patients with idiopathic normal pressure hydrocephalus (iNPH) serving as a contra
17 veness in individuals treated for idiopathic normal pressure hydrocephalus (iNPH), 37 patients clinic
18 ely 10% of dementia patients have idiopathic normal pressure hydrocephalus (iNPH), an expansion of th
19 inal tap test in individuals with idiopathic normal pressure hydrocephalus (iNPH), and explored if th
22 Alzheimer disease patients and patients with normal pressure hydrocephalus may have a higher risk of
26 the hypokinetic gait disorder in idiopathic normal pressure hydrocephalus (NPH) patients from the ga
28 s generally been demonstrated to be lower in normal pressure hydrocephalus (NPH) than in normal contr
29 (CSF) differentiate patients with suspected normal pressure hydrocephalus (NPH) who respond to CSF d
30 widely used to evaluate CSF hydrodynamics in normal pressure hydrocephalus (NPH), Chiari type I malfo
33 nation) in 36 shunt-responsive patients with normal-pressure hydrocephalus (NPH; mean age, 75 years;
34 d controls (ie, individuals with Bell palsy, normal pressure hydrocephalus, or Tourette syndrome).